230 related articles for article (PubMed ID: 31386933)
1. Transdermal lipid vesicular delivery of iloperidone: Formulation, in vitro and in vivo evaluation.
Londhe VY; Bhasin B
Colloids Surf B Biointerfaces; 2019 Nov; 183():110409. PubMed ID: 31386933
[TBL] [Abstract][Full Text] [Related]
2. Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil.
Mura S; Manconi M; Sinico C; Valenti D; Fadda AM
Int J Pharm; 2009 Oct; 380(1-2):72-9. PubMed ID: 19589377
[TBL] [Abstract][Full Text] [Related]
3. Design by optimization and comparative evaluation of vesicular gels of etodolac for transdermal delivery.
Madhavi N; Sudhakar B; Reddy KVNS; Ratna JV
Drug Dev Ind Pharm; 2019 Apr; 45(4):611-628. PubMed ID: 30712433
[TBL] [Abstract][Full Text] [Related]
4. Formulation and Characterization of Fast-Dissolving Sublingual Film of Iloperidone Using Box-Behnken Design for Enhancement of Oral Bioavailability.
Londhe V; Shirsat R
AAPS PharmSciTech; 2018 Apr; 19(3):1392-1400. PubMed ID: 29396734
[TBL] [Abstract][Full Text] [Related]
5. Application of Statistical Tooling Techniques for Designing of Carvedilol Nanolipid Transferosomes and its Dermatopharmacokinetic and Pharmacodynamic Studies.
Selvaraj BR; Sridhar SK; Kesavan BR; Palagati S
Pharm Nanotechnol; 2020; 8(6):452-470. PubMed ID: 32988361
[TBL] [Abstract][Full Text] [Related]
6. Transcutol containing vesicles for topical delivery of minoxidil.
Mura S; Manconi M; Valenti D; Sinico C; Vila AO; Fadda AM
J Drug Target; 2011 Apr; 19(3):189-96. PubMed ID: 20446805
[TBL] [Abstract][Full Text] [Related]
7. Formulation of niosomal gel for enhanced transdermal lopinavir delivery and its comparative evaluation with ethosomal gel.
Patel KK; Kumar P; Thakkar HP
AAPS PharmSciTech; 2012 Dec; 13(4):1502-10. PubMed ID: 23104306
[TBL] [Abstract][Full Text] [Related]
8. Penetration enhancer containing vesicles as carriers for dermal delivery of tretinoin.
Manconi M; Sinico C; Caddeo C; Vila AO; Valenti D; Fadda AM
Int J Pharm; 2011 Jun; 412(1-2):37-46. PubMed ID: 21530626
[TBL] [Abstract][Full Text] [Related]
9. Transdermal ethosomal gel nanocarriers; a promising strategy for enhancement of anti-hypertensive effect of carvedilol.
Ibrahim TM; Abdallah MH; El-Megrab NA; El-Nahas HM
J Liposome Res; 2019 Sep; 29(3):215-228. PubMed ID: 30272506
[TBL] [Abstract][Full Text] [Related]
10. Formulation and optimization of lacidipine loaded niosomal gel for transdermal delivery: In-vitro characterization and in-vivo activity.
Qumbar M; Ameeduzzafar ; Imam SS; Ali J; Ahmad J; Ali A
Biomed Pharmacother; 2017 Sep; 93():255-266. PubMed ID: 28738502
[TBL] [Abstract][Full Text] [Related]
11. Quality by design approach to understand the process of optimization of iloperidone nanostructured lipid carriers for oral bioavailability enhancement.
Mandpe L; Pokharkar V
Pharm Dev Technol; 2015 May; 20(3):320-9. PubMed ID: 24328553
[TBL] [Abstract][Full Text] [Related]
12. Nanoemulsion gel-based topical delivery of an antifungal drug: in vitro activity and in vivo evaluation.
Hussain A; Samad A; Singh SK; Ahsan MN; Haque MW; Faruk A; Ahmed FJ
Drug Deliv; 2016; 23(2):642-47. PubMed ID: 25013957
[TBL] [Abstract][Full Text] [Related]
13. Formulation of Niosomal Gel for Enhanced Transdermal Lornoxicam Delivery: In-Vitro and In-Vivo Evaluation.
El-Ridy MS; Yehia SA; Mohsen AM; El-Awdan SA; Darwish AB
Curr Drug Deliv; 2018; 15(1):122-133. PubMed ID: 28240177
[TBL] [Abstract][Full Text] [Related]
14. Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: In vitro characterization and in vivo pharmacokinetic assessment.
Kamran M; Ahad A; Aqil M; Imam SS; Sultana Y; Ali A
Int J Pharm; 2016 May; 505(1-2):147-58. PubMed ID: 27005906
[TBL] [Abstract][Full Text] [Related]
15. The role of surfactants in the formulation of elastic liposomal gels containing a synthetic opioid analgesic.
Singh S; Vardhan H; Kotla NG; Maddiboyina B; Sharma D; Webster TJ
Int J Nanomedicine; 2016; 11():1475-82. PubMed ID: 27114707
[TBL] [Abstract][Full Text] [Related]
16. Enhanced bioavailability of exemestane via proliposomes based transdermal delivery.
Jukanti R; Sheela S; Bandari S; Veerareddy PR
J Pharm Sci; 2011 Aug; 100(8):3208-3222. PubMed ID: 21404279
[TBL] [Abstract][Full Text] [Related]
17. Elastic liposomes mediated transdermal delivery of an anti-hypertensive agent: propranolol hydrochloride.
Mishra D; Garg M; Dubey V; Jain S; Jain NK
J Pharm Sci; 2007 Jan; 96(1):145-55. PubMed ID: 16960826
[TBL] [Abstract][Full Text] [Related]
18. Development of ibuprofen nanoliposome for transdermal delivery: Physical characterization, in vitro/in vivo studies, and anti-inflammatory activity.
Gaur PK; Bajpai M; Mishra S; Verma A
Artif Cells Nanomed Biotechnol; 2016; 44(1):370-5. PubMed ID: 25211229
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of the bioavailability of an antihypertensive drug by transdermal protransfersomal system: formulation and in vivo study.
Morsi NM; Aboelwafa AA; Dawoud MHS
J Liposome Res; 2018 Jun; 28(2):137-148. PubMed ID: 28264602
[TBL] [Abstract][Full Text] [Related]
20. QbD-based carbopol transgel formulation: characterization, pharmacokinetic assessment and therapeutic efficacy in diabetes.
Prasad PS; Imam SS; Aqil M; Sultana Y; Ali A
Drug Deliv; 2016; 23(3):1057-66. PubMed ID: 25033041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
